Published in Int J Artif Organs on October 01, 2002
Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One (2013) 0.93
Assessment of resin perfusion in hepatic failure in vitro and in vivo. World J Gastroenterol (2004) 0.83
AGO1 defines a novel locus of Arabidopsis controlling leaf development. EMBO J (1998) 5.62
Superroot, a recessive mutation in Arabidopsis, confers auxin overproduction. Plant Cell (1995) 5.55
AGO1, QDE-2, and RDE-1 are related proteins required for post-transcriptional gene silencing in plants, quelling in fungi, and RNA interference in animals. Proc Natl Acad Sci U S A (2000) 5.03
Sur2 mutations of Arabidopsis thaliana define a new locus involved in the control of auxin homeostasis. Plant J (1998) 2.81
The SUR2 gene of Arabidopsis thaliana encodes the cytochrome P450 CYP83B1, a modulator of auxin homeostasis. Proc Natl Acad Sci U S A (2000) 2.71
Procuste1 mutants identify two distinct genetic pathways controlling hypocotyl cell elongation, respectively in dark- and light-grown Arabidopsis seedlings. Development (1996) 2.34
Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med (1995) 2.07
Direct measurement of the 7Be solar neutrino flux with 192 days of borexino data. Phys Rev Lett (2008) 1.93
FACKEL is a sterol C-14 reductase required for organized cell division and expansion in Arabidopsis embryogenesis. Genes Dev (2000) 1.92
Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol (2004) 1.80
Higher activity of an aldehyde oxidase in the auxin-overproducing superroot1 mutant of Arabidopsis thaliana. Plant Physiol (1998) 1.61
Mutation in the Arabidopsis PASTICCINO1 gene, which encodes a new FK506-binding protein-like protein, has a dramatic effect on plant development. Mol Cell Biol (1998) 1.54
FKBPs: at the crossroads of folding and transduction. Trends Plant Sci (2001) 1.43
The PASTICCINO genes of Arabidopsis thaliana are involved in the control of cell division and differentiation. Development (1998) 1.36
Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol Suppl (1995) 1.21
Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis (1999) 1.19
A randomised control study comparing the Infant Flow Driver with nasal continuous positive airway pressure in preterm infants. Arch Dis Child Fetal Neonatal Ed (2001) 1.17
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone (2008) 1.16
A bioartificial liver to treat severe acute liver failure. Ann Surg (1994) 1.14
Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension (1999) 1.12
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology (2000) 1.11
Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab (1995) 1.09
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol (2001) 0.96
Use of a transient expression assay for the optimization of direct gene transfer into tobacco mesophyll protoplasts by electroporation. Biochimie (1988) 0.94
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology (2003) 0.94
Transmeatal low-level laser therapy for chronic tinnitus with cochlear dysfunction. Audiol Neurootol (2008) 0.94
Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 Mutations. Mol Syndromol (2012) 0.93
Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes (1995) 0.93
Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet (1993) 0.92
Lymphatic microsurgery for the treatment of lymphedema. Microsurgery (2006) 0.91
Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transpl Infect Dis (2010) 0.91
Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes (1999) 0.90
Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes (1997) 0.90
A comparison of two-dimensional electrophoresis data with phenotypical traits in Arabidopsis leads to the identification of a mutant (cri1) that accumulates cytokinins. Planta (1997) 0.89
Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology (2009) 0.89
Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant (1995) 0.89
Anastomosis of nasal mucosal and lacrimal sac flaps in endoscopic dacryocystorhinostomy. Eur Arch Otorhinolaryngol (2009) 0.89
Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol (1995) 0.88
Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. Am J Hypertens (1998) 0.88
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. Parkinsonism Relat Disord (2004) 0.87
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes (1998) 0.87
Nonhomologous Robertsonian translocations (NHRTs) and uniparental disomy (UPD) risk: an Italian multicentric prenatal survey. Prenat Diagn (2004) 0.86
Oscillatory potentials in subjects with treated hypertension. Ophthalmologica (1995) 0.85
Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: influence of dietary sodium load and depletion. Hypertension (1998) 0.85
Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies. Diabetes (1997) 0.85
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. Br J Pharmacol (2014) 0.84
[Carbon dioxide embolization: is it a complication of laparoscopic cholecystectomy? ]. Minerva Chir (2003) 0.84
Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage. Exp Clin Endocrinol Diabetes (1997) 0.84
Biologic liver support: optimal cell source and mass. Int J Artif Organs (2002) 0.84
An update on high-yield hepatocyte isolation methods and on the potential clinical use of isolated liver cells. Comp Biochem Physiol A Mol Integr Physiol (1998) 0.83
Efficacy of low-level laser therapy in Ménière's disease: a pilot study of 10 patients. Photomed Laser Surg (2008) 0.83
Asymptomatic intracranial hypertension associated with tetracycline use. Pediatr Infect Dis J (1999) 0.83
Body fluid volumes in the spontaneously hypertensive rat. Clin Sci (Lond) (1981) 0.83
Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction. J Urol (1997) 0.82
Age, gender, and non-modulation. A sexual dimorphism in essential hypertension. Hypertension (1997) 0.82
Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor. Eur J Hum Genet (2000) 0.81
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor. J Inherit Metab Dis (1996) 0.81
Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition. Am J Hypertens (1995) 0.81
The A1 adenosine receptor as a new player in microglia physiology. Glia (2014) 0.81
Prenatal cocaine exposure and the expanding spectrum of brain malformations. Arch Intern Med (2000) 0.80
Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int (1994) 0.80
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor. Artif Organs (2001) 0.80
Serum bile acids in patients with liver failure supported with a bioartificial liver. Aliment Pharmacol Ther (2002) 0.80
Elevated plasma and urinary endothelin-I levels in human salt-sensitive hypertension. Clin Sci (Lond) (1997) 0.80
[Crouzon's syndrome. Description of a case treated surgically in the fifth month of life]. Pediatr Med Chir (1985) 0.80
Slipped capital femoral epiphysis associated with Rubinstein-Taybi syndrome. Clin Genet (1993) 0.80
Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice. Int J Artif Organs (2000) 0.80
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease. Clin Neuropharmacol (1999) 0.79
Neither physical exercise nor alpha 1- and beta-adrenergic blockade affect plasma endothelin concentrations. Am J Hypertens (1996) 0.79
Bosentan reduces blood pressure and the target-organ damage induced by a high-fructose diet in rats. J Hypertens (1999) 0.79
A technical proposal for the complex flail chest. Ann Thorac Surg (2000) 0.79
Vascular Anomalies Guidelines by the Italian Society for the study of Vascular Anomalies (SISAV). Int Angiol (2015) 0.79
Is there a role for microsurgery in the prevention of arm lymphedema secondary to breast cancer treatment? Microsurgery (2006) 0.79
Early effects of diabetes on inducible nitric oxide synthase in the kidney. Acta Diabetol (2002) 0.79
Stiff-person syndrome with acute recurrent peripheral vertigo: possible evidence of gamma aminobutyric acid as a neurotransmitter in the vestibular periphery. J Laryngol Otol (2007) 0.79
Fumarate hydratase deficiency. J Inherit Metab Dis (1998) 0.79
A novel mutation (R218Q) at the boundary between the N-terminal and the first transmembrane domain of the glycine receptor in a case of sporadic hyperekplexia. J Med Genet (2003) 0.79
Pseudolithiasis and intractable hiccups in a boy receiving ceftriaxone. N Engl J Med (1994) 0.78
Pancreatic beta-cell replication in streptozotocin-diabetic rats: the effect of liver compensatory growth on intraportally engrafted islets. Pancreas (1999) 0.78
Blood endothelin-1 levels before and after carotid endoarterectomy for atherosclerotic stenosis. Atherosclerosis (2001) 0.78
[Fulminant liver failure: etiopathogenesis and therapy]. Ann Ital Chir (2000) 0.78
Rapid intestinal transit and postgastrectomy malnutrition. An experimental study in growing rats. Ital J Surg Sci (1985) 0.78
Diagnosis of neonatal hemochromatosis with MR imaging and duplex Doppler sonography. Eur Radiol (1999) 0.77
High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients. Kidney Int (1999) 0.77
Assessment and improvement of liver specific function of the AMC-bioartificial liver. Int J Artif Organs (2005) 0.77
Neurogenic activity--angiotensin II interaction during the development and maintenance of renal hypertension in the rat. Clin Sci (Lond) (1979) 0.77
Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levels. Clin Sci (Lond) (1999) 0.77
Surgical prevention and treatment of lymphedema after lymph node dissection in patients with cutaneous melanoma. Lymphology (2013) 0.77
Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care (1996) 0.77
A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia. Eur J Hum Genet (2001) 0.77
Cristal mutations in Arabidopsis confer a genetically heritable, recessive, hyperhydric phenotype. Planta (1997) 0.77
The origin of bile ductular-like structures after transplantation of regenerating hepatocytes into the spleen of syngeneic rats. Ital J Surg Sci (1987) 0.77
Active kallikrein response to changes in sodium-chloride intake in essential hypertensive patients. J Am Soc Nephrol (1996) 0.77
Autosomal recessive mode of inheritance of a Coffin-Siris like syndrome. Genet Couns (1995) 0.77
Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients. Circulation (1994) 0.77
Lacidipine reduces high blood pressure and the target organ damage induced by high fructose diet in rats. J Hypertens (1999) 0.77
Radiological case of the month. Sinus pericranii. Arch Pediatr Adolesc Med (1994) 0.77
[Acute and fulminant liver failure: experimental models]. Ann Ital Chir (2000) 0.76
Antihypertensive treatment with enrasentan (SB217242) in an animal model of hypertension and hyperinsulinemia. J Cardiovasc Pharmacol (2002) 0.76
Rizatriptan does not change cerebral blood flow velocity during migraine attacks. Brain Res Bull (2005) 0.76